Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1982 2
1983 10
1984 12
1985 18
1986 39
1987 13
1988 12
1989 16
1990 47
1991 30
1992 38
1993 33
1994 47
1995 35
1996 42
1997 36
1998 40
1999 28
2000 22
2001 32
2002 32
2003 37
2004 30
2005 24
2006 25
2007 27
2008 19
2009 24
2010 32
2011 26
2012 27
2013 26
2014 29
2015 45
2016 41
2017 30
2018 44
2019 38
2020 33
2021 40
2022 38
2023 35
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

1,201 results

Results by year

Filters applied: . Clear all
Page 1
Simultaneous quantification of pirarubicin, doxorubicin, cyclophosphamide, and vincristine in human plasma of patients with non-Hodgkin's lymphoma by LC-MS/MS method.
Qi P, Li P, Qiao L, Xue H, Ma Y, Wei S, Yang X, Zhang H, Zhang Y, Wang Y, He S, Quan H, Zhang W. Qi P, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2023 May 30;1224:123754. doi: 10.1016/j.jchromb.2023.123754. Epub 2023 May 15. J Chromatogr B Analyt Technol Biomed Life Sci. 2023. PMID: 37229818
Pirarubicin (THP), doxorubicin (DOX), cyclophosphamide (CTX), and vincristine (VCR) are widely used in the treatment of patients with non-Hodgkin's Lymphoma. ...
Pirarubicin (THP), doxorubicin (DOX), cyclophosphamide (CTX), and vincristine (VCR) are widely used in the treatment of patients with …
[Pirarubicin (THP-adriamycin)].
Tsukagoshi S. Tsukagoshi S. Gan To Kagaku Ryoho. 1988 Sep;15(9):2819-27. Gan To Kagaku Ryoho. 1988. PMID: 3046496 Review. Japanese.
Pirarubicin (THP-adriamycin or THP-doxorubicin) was found during a search of new anthracycline antibiotics among 4'-O-substituted compounds having less toxicities than other anthracycline anticancer drugs in 1979 by Umezawa et al. ...
Pirarubicin (THP-adriamycin or THP-doxorubicin) was found during a search of new anthracycline antibiotics among 4'-O-substituted com …
Prospects for pirarubicin.
Miller AA, Salewski E. Miller AA, et al. Med Pediatr Oncol. 1994;22(4):261-8. doi: 10.1002/mpo.2950220410. Med Pediatr Oncol. 1994. PMID: 8107658 Review. No abstract available.
CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis.
Ma J, Chen C, Fan Z, Zhang Y, Ji J, Wei D, Zhang F, Sun B, Huang P, Ren L. Ma J, et al. Int J Biol Macromol. 2023 Jul 31;244:125295. doi: 10.1016/j.ijbiomac.2023.125295. Epub 2023 Jun 9. Int J Biol Macromol. 2023. PMID: 37302631
However, the biological function of circRNAs in triple-negative breast cancer (TNBC) and its effect on the sensitivity to pirarubicin (THP) chemotherapy are still unclear. CircEGFR (hsa_circ_0080220) was screened and verified by bioinformatics analysis, proving it was high …
However, the biological function of circRNAs in triple-negative breast cancer (TNBC) and its effect on the sensitivity to pirarubicin …
The application of gemcitabine and pirarubicin in patients with non-muscle invasive bladder cancer.
Wang L, Huang S, Zhang P, Li H, Li Z, Xue L, Wang Z, Chen Q, Fu D, Luo Q, Li H. Wang L, et al. J Cancer Res Clin Oncol. 2023 Sep;149(11):8945-8949. doi: 10.1007/s00432-023-04739-6. Epub 2023 May 9. J Cancer Res Clin Oncol. 2023. PMID: 37160625
OBJECTIVE: To investigate the value of gemcitabine and pirarubicin in patients with non-muscle-invasive bladder cancer (NMIBC). ...In the Gemcitabine group, bladder irritation signs, meatus hematuria, fever, nausea and vomiting were lower than those in the Pirarubicin …
OBJECTIVE: To investigate the value of gemcitabine and pirarubicin in patients with non-muscle-invasive bladder cancer (NMIBC). ...In …
Pirarubicin-loaded CalliSpheres drug-eluting beads for the treatment of patients with stage III-IV lung cancer.
Bi Y, Shi X, Yi M, Han X, Ren J. Bi Y, et al. Acta Radiol. 2022 Mar;63(3):311-318. doi: 10.1177/0284185121994298. Epub 2021 Feb 20. Acta Radiol. 2022. PMID: 33615822
PURPOSE: To evaluate the safety and efficacy of DEB-TACE with pirarubicin-loaded CB for the treatment of stage III-IV lung cancer. ...RESULTS: Twenty-nine patients received DEB-TACE with pirarubicin-loaded (median 60 mg) CB, with no severe adverse events or treatmen …
PURPOSE: To evaluate the safety and efficacy of DEB-TACE with pirarubicin-loaded CB for the treatment of stage III-IV lung cancer. .. …
RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma.
Huang H, Chen T, Zhou Y, Geng L, Shen T, Zhou L, Zheng S. Huang H, et al. Int J Med Sci. 2018 Nov 5;15(14):1648-1657. doi: 10.7150/ijms.28289. eCollection 2018. Int J Med Sci. 2018. PMID: 30588188 Free PMC article.
Pirarubicin (THP) is a new generation cell cycle nonspecific anthracycline anticancer drug. Pirarubicin and pirarubicin-based combination therapies have been demonstrated to be effective against HCC in TACE. ...
Pirarubicin (THP) is a new generation cell cycle nonspecific anthracycline anticancer drug. Pirarubicin and pirarubicin …
MiR-494-3p aggravates pirarubicin-induced cardiomyocyte injury by regulating MDM4/p53 signaling pathway.
Huang P, Zhang Y, Wang F, Qin M, Ma J, Ji J, Wei D, Ren L. Huang P, et al. Environ Toxicol. 2023 Oct;38(10):2499-2508. doi: 10.1002/tox.23888. Epub 2023 Jul 8. Environ Toxicol. 2023. PMID: 37421283
OBJECTIVE: Pirarubicin (THP) is a widely used antitumor drug in clinical practice, but its cardiotoxicity limits its use. ...
OBJECTIVE: Pirarubicin (THP) is a widely used antitumor drug in clinical practice, but its cardiotoxicity limits its use. ...
Anaphylactic shock due to intravesical administration of pirarubicin hydrochloride for the fifth time.
Sakata K, Fukuoka N, Tanabe K, Takenaka M, Iida H. Sakata K, et al. J Clin Anesth. 2016 Feb;28:2-3. doi: 10.1016/j.jclinane.2015.08.001. Epub 2015 Nov 11. J Clin Anesth. 2016. PMID: 26796606
We report the first case of anaphylaxis induced by intravesical administration of pirarubicin hydrochloride during spinal anesthesia. The patient was a 64-year-old woman being followed up for transitional cell carcinoma of the bladder. Anaphylaxis occurred the fifth …
We report the first case of anaphylaxis induced by intravesical administration of pirarubicin hydrochloride during spinal anes …
Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
Liu M, Yang J, Lv W, Wang S, Du T, Zhang K, Wu Y, Feng X. Liu M, et al. Biosci Rep. 2022 Jan 28;42(1):BSR20210245. doi: 10.1042/BSR20210245. Biosci Rep. 2022. PMID: 34935899 Free PMC article.
To study the chemoresistance mechanisms, we first screened compounds on a pirarubicin-resistant cell line (MDA-MB-231R) derived from MDA-MB-231. ...Transfecting MDA-MB-231R cells with a siGRP78 plasmid reduced GRP78 expression, which restored pirarubicin sensitivity …
To study the chemoresistance mechanisms, we first screened compounds on a pirarubicin-resistant cell line (MDA-MB-231R) derived from …
1,201 results